Evaluating Short-course Antibiotic Therapy for Pediatric Community-acquired Pneumonia: A Systematic Review and
Erdenetuya Bolormaa1, Cho Ryok Kang2, Young June Choe3,2
1From the Department of Preventive Medicine.
Insights
Short-course antibiotic therapy for pediatric community-acquired pneumonia (CAP) is as effective as long-course treatment. This approach leads to fewer serious adverse events and similar clinical cure rates.
Area of Science:
- Pediatric infectious diseases
- Pharmacotherapy research
- Clinical trial analysis
Background:
- Optimal antibiotic duration for pediatric community-acquired pneumonia (CAP) is not well-defined.
- Uncertainty exists regarding the clinical outcomes of short-course (≤6 days) versus long-course (>7 days) antibiotic therapy in children with CAP.
Purpose of the Study:
- To evaluate the efficacy and safety of short-course antibiotic therapy compared to long-course therapy in pediatric CAP.
- To determine if shorter antibiotic durations are associated with poorer clinical outcomes.
Main Methods:
- A systematic literature search was performed across major databases (PubMed, Embase, Cochrane Library, KoreaMed).
- Included studies compared short-course versus long-course antibiotic regimens in pediatric CAP patients.
- Meta-analysis of pooled risk ratios (RRs) and 95% confidence intervals (CIs) was conducted for key clinical outcomes.
Main Results:
- Seventeen studies involving 155,944 children were analyzed.
- No significant differences were found in clinical cure or treatment failure between short-course and long-course antibiotic treatments.
- Short-course therapy was associated with fewer serious adverse events and nominally lower relapse rates.
Conclusions:
- Short-course antibiotic treatment demonstrates comparable efficacy to long-course treatment for pediatric CAP.
- The findings support the use of shorter antibiotic durations, as they are associated with a reduced risk of serious adverse events.
Background:
The optimal duration of antibiotic therapy for community-acquired pneumonia (CAP) in children remains uncertain. In this study, we aimed to evaluate whether short-course antibiotic therapy (≤6 days) is associated with poor clinical outcomes compared with long-course antibiotic therapy (>7 days) in children with CAP.
Methods:
A comprehensive search was conducted across databases, including PubMed, Embase, Cochrane Library, and KoreaMed. Studies comparing the efficacy and safety of short-course with long-course antibiotic regimens in children with CAP were eligible. We assessed the risk of bias using the RoB 2 and ROBINS-I tools. Study characteristics such as publication year, country, setting, study design and antibiotic regimens were recorded. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated for clinical outcomes, including clinical cure, treatment failure, total adverse events, serious adverse events, relapse and hospitalization. The primary outcomes were clinical cure and treatment failure. Secondary outcomes included total and serious adverse events, relapse and hospitalization rates.
Results:
Seventeen studies comprising 155,944 children met the inclusion criteria, with 15 of these studies being randomized controlled trials. There were no significant differences between short-course and long-course treatments in clinical cure [21,156 patients; RR, 1.01 (95% CI, 0.97-1.05); P = 0.73; I² = 81%], treatment failure [28,942 patients; RR, 0.88 (95% CI, 0.51-1.51); P = 0.64; I² = 94%] or total adverse events [24,446 children; RR, 0.94 (95% CI, 0.61-1.44); P = 0.77; I² = 90%]. However, short-course treatment was associated with fewer serious adverse events [4194 patients; RR, 0.89 (95% CI, 0.79-0.99); P = 0.04; I² = 11%]. Relapse rates were nominally lower with short-course treatment compared with long-course treatments (5.5% vs. 6.2%; P = 0.04). This difference was primarily observed in the subgroup analysis comparing 5-day treatments to ≥10-day treatments. Hospitalization rates were similar between the two groups [122,607 patients; RR, 1.20 (95% CI, 0.85-1.68); P = 0.29; I² = 0%].
Conclusions:
Short-course antibiotic treatment is as effective as long-course treatment for pediatric CAP in terms of clinical cure and treatment failure while resulting in fewer serious adverse events.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...